PARAMETRIC PORTFOLIO ASSOCIATES LLC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 101 filers reported holding SPERO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$384,000
+84.6%
44,168
+290.6%
0.00%
Q3 2021$208,000
-50.2%
11,308
-62.2%
0.00%
Q2 2021$418,000
-9.7%
29,947
-4.7%
0.00%
Q1 2021$463,000
-6.3%
31,437
+23.5%
0.00%
Q4 2020$494,000
+214.6%
25,455
+119.9%
0.00%
Q2 2020$157,000
+61.9%
11,575
+15.1%
0.00%
Q4 2019$97,00010,0530.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders